|
FAM200A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.03869999455031E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82470000004353E-07 |
| Normal-vs-Stage2 |
4.986800E-04 |
| Normal-vs-Stage3 |
1.79660000210191E-08 |
| Normal-vs-Stage4 |
3.51100004625238E-09 |
| Stage1-vs-Stage2 |
3.592000E-01 |
| Stage1-vs-Stage3 |
7.224100E-02 |
| Stage1-vs-Stage4 |
1.149770E-02 |
| Stage2-vs-Stage3 |
5.954400E-02 |
| Stage2-vs-Stage4 |
1.388180E-02 |
| Stage3-vs-Stage4 |
3.212200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.14270000315531E-08 |
| Normal-vs-AfricanAmerican |
8.843600E-04 |
| Normal-vs-Asian |
2.16659999999758E-05 |
| Caucasian-vs-AfricanAmerican |
9.802000E-01 |
| Caucasian-vs-Asian |
4.514200E-01 |
| AfricanAmerican-vs-Asian |
6.707200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62149999982653E-07 |
| Normal-vs-Female |
1.07820000039283E-07 |
| Male-vs-Female |
8.670200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.81539999980041E-07 |
| Normal-vs-Age(41-60Yrs) |
1.79600001537494E-09 |
| Normal-vs-Age(61-80Yrs) |
3.4191000031214E-08 |
| Normal-vs-Age(81-100Yrs) |
2.095900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.787800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.516600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.382800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.269200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.157200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.779000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.407820E-04 |
| Classical-VS-Follicular |
9.965000E-01 |
| Classical-VS-Other |
6.414000E-01 |
| Classical-VS-Normal |
1.04310000004215E-06 |
| Tall-VS-Follicular |
1.157210E-03 |
| Tall-VS-Other |
1.456210E-01 |
| Tall-VS-Normal |
1.9099999359895E-10 |
| Follicular-VS-Other |
6.760600E-01 |
| Follicular-VS-Normal |
1.37109999998053E-06 |
| Other-VS-Normal |
1.045610E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67450000532199E-08 |
| Normal-vs-N1 |
8.66549999978261E-07 |
| N0-vs-N1 |
3.825600E-01 |
|
|
